文献速递慢性肾脏病

非透析慢性肾脏病中绝对与功能性缺铁性贫血的患病率、相关因素及结局

Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease.
PubMed 文献 · Nephrol Dial Transplant · 2021-01-01

基于美国退伍军人管理局93万余例非透析CKD患者数据,20.6%存在贫血;在同时检测转铁蛋白饱和度与铁蛋白的贫血患者中,30%为绝对性缺铁性贫血、19%为功能性缺铁性贫血。功能性缺铁性贫血与死亡及心血管住院风险升高相关,而绝对性缺铁性贫血仅与心血管住院风险升高相关。

要点

  • 非透析CKD患者贫血患病率为20.6%。
  • 功能性缺铁性贫血与死亡和心血管住院风险升高相关。
  • 绝对性缺铁性贫血仅与心血管住院风险升高相关,与死亡和透析无关。

核心结论

  • 在非透析CKD贫血患者中,功能性缺铁性贫血与死亡及心血管住院风险升高相关,绝对性缺铁性贫血仅与心血管住院风险升高相关。

主要发现

  • 贫血患者中23.6%同时检测了TSAT和铁蛋白,其中30%为绝对性缺铁性贫血、19%为功能性缺铁性贫血。
  • 绝对性缺铁性贫血与1年心血管住院风险升高相关(RR 1.20,95%CI 1.12-1.28),与2年心血管住院风险升高相关(RR 1.11,95%CI 1.05-1.17),与死亡或透析风险无关。
  • 功能性缺铁性贫血与死亡风险升高相关(HR 1.11,95%CI 1.07-1.14),与1年心血管住院风险升高相关(RR 1.21,95%CI 1.1-1.30),与2年心血管住院风险升高相关(RR 1.13,95%CI 1.07-1.21)。
  • 铁蛋白>500 ng/mL仅与死亡风险升高相关(HR 1.38,95%CI 1.26-1.51)。

关键数值与推荐

  • 绝对性缺铁性贫血定义:TSAT≤20%且铁蛋白<100 ng/mL。
  • 功能性缺铁性贫血定义:TSAT≤20%且铁蛋白>100-500 ng/mL。

临床怎么用

  • 在非透析CKD贫血患者中应区分绝对性与功能性缺铁性贫血,功能性缺铁性贫血提示死亡和心血管住院风险更高。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anemia is associated with adverse outcomes in those with chronic kidney disease (CKD). We examined the association of absolute and functional iron deficiency anemia (IDA) with adverse outcomes (cardiovascular hospitalization, dialysis and mortality) in those with nondialysis-dependent CKD. METHODS: Nondialysis-dependent CKD patients followed in the US Veterans Administration with hemoglobin level measured within 90 days of the date of the second estimated glomerular filtration rate <60 mL/min/1.73 m2 were included. Logistic regression, multivariate Cox proportional hazards and Poisson regression models adjusted for demographics and comorbidities were used to assess the prevalence and correlates of absolute [transferrin saturation (TSAT) ≤20%, ferritin <100 ng/mL] and functional (TSA T≤20%, ferritin >100-500 ng/mL) IDA and the associations of absolute and functional IDA with mortality, dialysis and cardiovascular hospitalization. RESULTS: Of 933 463 patients with CKD, 20.6% had anemia. Among those with anemia, 23.6% of patients had both TSAT and ferritin level measured, of whom 30% had absolute IDA and 19% had functional IDA. Absolute IDA in CKD was not associated with an increased risk of mortality or dialysis but was associated with a higher risk of 1-year {risk ratio [RR] 1.20 [95% confidence interval (CI) 1.12-1.28]} and 2-year cardiovascular hospitalization [RR 1.11 (95% CI 1.05-1.17)]. CKD patients with functional IDA had a higher risk of mortality [hazard ratio (HR) 1.11 (95% CI 1.07-1.14)] along with a higher risk of 1-year [RR 1.21 (95% CI 1.1-1.30)] and 2-year cardiovascular hospitalization [RR 1.13 (95% CI 1.07-1.21)]. Ferritin >500 ng/mL (treated as a separate category) was only associated with an increased risk of mortality [HR 1.38 (95% CI 1.26-1.51)]. CONCLUSIONS: In a large population of CKD patients with anemia, absolute and functional IDA were associated with various clinical covariates. Functional IDA was associated with an increased risk of mortality and cardiovascular hospitalization, but absolute IDA was associated only with a higher risk of hospitalization.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Awan AA, Walther CP, Richardson PA, et al. Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease. Nephrol Dial Transplant. 2021. PMID: 31641775. doi:10.1093/ndt/gfz192

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。